Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Harvard Review of Psychiatry|March 4, 2021
Acquisition and Interpretation of Digital Information in Forensic AssessmentsBarbara Burton, Eric Y Drogin
Molecular Genetics and Metabolism|November 27, 2007
Recommendations for evaluation of responsiveness to tetrahydrobiopterin (BH(4)) in phenylketonuria and its use in treatmentHarvey Levy, Barbara Burton, Stephen Cederbaum, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|October 30, 2018
A longitudinal study of housing status and crime in a homeless populationBarbara Burton, David E Pollio, Carol S North
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 14, 2012
Follow-up of patients with short-chain acyl-CoA dehydrogenase and isobutyryl-CoA dehydrogenase deficiencies identified through newborn screening: one center's experienceLoren Pena, Brad Angle, Barbara Burton, et al.
Molecular Genetics and Metabolism|February 4, 2010
Outcomes beyond phenylalanine: an international perspectiveFrancois Feillet, Anita MacDonald, Danielle Hartung Perron, et al.
Molecular Genetics and Metabolism|May 28, 2023
Challenges and strategies for clinical trials in propionic and methylmalonic acidemiasJerry Vockley, Barbara Burton, Agnieszka Jurecka, et al.
Molecular Genetics and Metabolism|July 9, 2026
Biomarkers and surrogate endpoints for drug development in propionic acidemiaAgnieszka Jurecka, Sabine Scholl-Bürgi, Barbara Burton, et al.
Pediatric Research|April 17, 2008
N-carbamylglutamate markedly enhances ureagenesis in N-acetylglutamate deficiency and propionic acidemia as measured by isotopic incorporation and blood biomarkersMendel Tuchman, Ljubica Caldovic, Yevgeny Daikhin, et al.
Molecular Genetics and Metabolism|August 24, 2019
Long-term comparative effectiveness of pegvaliase versus standard of care comparators in adults with phenylketonuriaRoberto Zori, Kirsten Ahring, Barbara Burton, et al.
Molecular Genetics and Metabolism|December 7, 2024
High precision newborn screening for mucopolysaccharidosis type I by enzymatic activity followed by endogenous, non-reducing end glycosaminoglycan analysisZackary M Herbst, Francyne Kubaski, Laura Pollard, et al.
Pageof 4